Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy

Abroad (travel likely)RecruitingPHASE2

Conditions

Cerebral Palsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Shirley Ryan AbilityLab, Chicago, Illinois, United States

Study leads
  • Megan O'Brien, PhD

    Principal Investigator

    Shirley Ryan AbilityLab